Do not rush the titration schedule
The foundational characterization appeared in European Journal of Endocrinology in 1998, reporting selective agonism of the growth hormone secretagogue receptor type 1a (GHS-R1a) without significant elevation of ACTH, cortisol, prolactin, FSH, LH, or TSH, even at doses 200-fold above the GH-releasing ED50 in preclinical models
Since its discovery in the early 1990s, BPC-157 has been studied extensively in laboratory and animal models for its potential influence on cellular protection, structural repair, and angiogenic processes
Tissue distribution Tissue distribution studies in rodent models suggest BPC-157 distributes broadly with notable accumulation in GI mucosa (consistent with its biological origin as a gastric-juice fragment)
454 By reducing MMP expression, GLP-1R stimulation may help preserve the integrity of fibrous caps and mitigate the risk of plaque rupture
Shots for energy work faster than most people think